Pharmalex - Public Affairs, Communication & Patient Advocacy company information, Employees & Contact Information

Opportunities and Obstacles for Personalized Cancer Vaccines BioProcess International

PharmaLex to merge with Cpharm to enhance presence in Australia Pharmaceutical Technology

Behind AmerisourceBergen's PharmaLex buy Axios

PharmaLex forms joint venture with consulting firm Vintura Consultancy.eu

Growth of Combination Products & Australian Regulatory Updates BioProcess International

Supporting Mergers and Acquisitions in the Pharmaceutical/Biopharmaceutical Industry Global Trade Magazine

3 Q&A Interview with Torben Thers Nørgaard General Manager, Cencora Pharmalex Nordic mva.org

PharmaLex announces joint venture with Vintura PMLiVE

PharmaLex enters merger deal with Ascent Development Services Pharmaceutical Technology

AmerisourceBergen agrees to acquire PharmaLex for $1.29bn Pharmaceutical Technology

Best-Practice Quality Trends. Going Beyond the Basics in Risk Management BioProcess International

ATMPs: Chemistry, Manufacturing, and Controls BioProcess International

From PDFs to Digital Submissions The Rapid Pace of Regulatory Change BioProcess International

The State of Quality Risk Management in the Pharmaceutical Industry: Commentary on the Draft ICH Q9 Revision BioProcess International

Centralize, Modernize, Harmonize: The Acceleration of Regulatory Digital Trends BioProcess International

Analytical Method Validation Challenges for Advanced Therapies: Using Gene Therapies as an Example BioProcess International

Biopharmaceutical Industry Virtual Audits BioProcess International

Standard Operating Procedures in a Good Practice Environment: Benefit or Burden? BioProcess International

Orphan Drug Designation: Securing the Significant Benefits BioProcess International

Preparing for a Virtual Audit BioProcess International

AmerisourceBergen to acquire German biopharma services provider for $1.3B The Business Journals

Focus on Aseptic Processing: A Report from the September 2022 PDA Annex 1 Event in Amsterdam BioProcess International

PharmaLex strengthens global reach and local support with offices in China BioSpectrum Asia

AUCTUS Capital exits PharmaLex to AmerisourceBergen pehub.com

PharmaLex expands its footprint to Italy PMLiVE

PharmaLex strengthens international team PMLiVE

PharmaLex enters Australia following acquisition of ERA Consulting Consultancy.com.au

Rules on Ownership of Medicinal Product stock distributed in Great Britain PharmiWeb.com

Regulatory divergence presents barriers to EU combined studies Teknologiateollisuus ry

Piper Alderman assists PharmaLex’s merger with specialist consultancy Australasian Lawyer